EUSEBI, PAOLO
 Distribuzione geografica
Continente #
NA - Nord America 4.466
EU - Europa 3.536
AS - Asia 3.124
SA - Sud America 492
AF - Africa 80
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 3
Totale 11.707
Nazione #
US - Stati Uniti d'America 4.353
SG - Singapore 1.465
IT - Italia 1.254
IE - Irlanda 553
CN - Cina 463
BR - Brasile 384
HK - Hong Kong 371
RU - Federazione Russa 360
VN - Vietnam 352
FR - Francia 261
DE - Germania 237
UA - Ucraina 194
FI - Finlandia 136
GB - Regno Unito 112
SE - Svezia 102
IN - India 98
NL - Olanda 76
BD - Bangladesh 55
KR - Corea 55
CA - Canada 50
TR - Turchia 50
IQ - Iraq 45
RO - Romania 41
AR - Argentina 38
MX - Messico 36
PL - Polonia 36
JP - Giappone 34
ES - Italia 30
AT - Austria 29
ZA - Sudafrica 27
CH - Svizzera 26
CZ - Repubblica Ceca 23
PK - Pakistan 20
VE - Venezuela 18
UZ - Uzbekistan 17
CO - Colombia 16
BE - Belgio 15
ID - Indonesia 15
LT - Lituania 15
CL - Cile 12
JO - Giordania 11
SA - Arabia Saudita 10
GR - Grecia 9
MA - Marocco 9
DZ - Algeria 8
EC - Ecuador 8
PH - Filippine 7
TN - Tunisia 7
AL - Albania 6
JM - Giamaica 6
KE - Kenya 6
KG - Kirghizistan 6
PY - Paraguay 6
AU - Australia 5
AZ - Azerbaigian 5
ET - Etiopia 5
LB - Libano 5
SY - Repubblica araba siriana 5
UY - Uruguay 5
CI - Costa d'Avorio 4
EG - Egitto 4
IL - Israele 4
MY - Malesia 4
NI - Nicaragua 4
NP - Nepal 4
OM - Oman 4
SI - Slovenia 4
AE - Emirati Arabi Uniti 3
BG - Bulgaria 3
CR - Costa Rica 3
HN - Honduras 3
HR - Croazia 3
PA - Panama 3
SN - Senegal 3
BH - Bahrain 2
BO - Bolivia 2
DK - Danimarca 2
EU - Europa 2
GA - Gabon 2
HU - Ungheria 2
KZ - Kazakistan 2
PE - Perù 2
SV - El Salvador 2
TJ - Tagikistan 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BS - Bahamas 1
BY - Bielorussia 1
CY - Cipro 1
DM - Dominica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GE - Georgia 1
GH - Ghana 1
GY - Guiana 1
KW - Kuwait 1
LC - Santa Lucia 1
LK - Sri Lanka 1
Totale 11.692
Città #
Singapore 1.084
Chandler 650
Dublin 553
San Jose 412
Hong Kong 365
Ashburn 305
Perugia 302
San Mateo 258
Boardman 182
Santa Clara 147
Moscow 138
Altamura 135
Beijing 130
Wilmington 129
Dong Ket 121
Medford 113
Princeton 112
Lauterbourg 103
Munich 97
Lawrence 95
Jacksonville 91
Des Moines 80
Ho Chi Minh City 78
Los Angeles 77
Milan 72
Andover 69
Rome 60
Hanoi 56
New York 56
The Dalles 56
Seoul 55
Ann Arbor 47
Helsinki 41
São Paulo 38
Turku 35
Frankfurt am Main 32
Bucharest 30
Houston 27
Orem 27
Tokyo 27
Atlanta 26
Chennai 25
Bologna 24
Brooklyn 24
Dallas 23
Norwalk 23
Poplar 23
Saint Petersburg 23
Denver 22
Izmir 22
Nuremberg 22
Chicago 21
Salerno 21
Council Bluffs 20
Warsaw 20
Falls Church 19
Baghdad 18
Genoa 18
Montreal 18
Piscataway 18
Amsterdam 17
Mexico City 17
Phoenix 17
Brussels 15
London 15
Modena 15
Seattle 15
Stockholm 15
Verona 15
Brno 14
Falkenstein 14
Haiphong 14
Johannesburg 14
Redwood City 14
Vienna 14
Boston 13
San Paolo di Civitate 13
Turin 13
Ankara 12
Dearborn 12
Manchester 12
Amman 11
San Francisco 11
Shanghai 11
Hefei 10
New Delhi 10
Saint Louis 10
Tashkent 10
Toronto 10
Columbus 9
Lausanne 9
Padova 9
Rio de Janeiro 9
Belo Horizonte 8
Caracas 8
Catania 8
Mumbai 8
Naples 8
Parma 8
Trento 8
Totale 7.390
Nome #
The validation of an Italian version of the Freezing of Gait Questionnaire 793
CSF and blood biomarkers for Parkinson's disease 202
Deviation from intention to treat analysis in randomised trials and treatment effect estimates: meta-epidemiological study 163
A diagnostic accuracy study validating cardiovascular ICD-9-CM codes in healthcare administrative databases. The Umbria data-value project 163
Accuracy of ICD-9 codes in identifying patients with peptic ulcer and gastrointestinal hemorrhage in the regional healthcare administrative database of Umbria 149
Time trends, frequency, characteristics and prognosis of short-duration transient global amnesia 145
Disturbi del comportamento alimentare nei maschi: l'importanza della distorsione dell'immagine corporea. 141
Interatrial Shunting Through an Asymptomatic Patent Foramen Ovale in Thoracic Surgery 140
Cerebrospinal fluid free light chains compared to oligoclonal bands as biomarkers in multiple sclerosis 138
Validating malignant melanoma ICD-9-CM codes in Umbria, ASL Napoli 3 Sud and Friuli Venezia Giulia administrative healthcare databases: a diagnostic accuracy study 137
Cerebrospinal fluid β-glucocerebrosidase activity is reduced in parkinson's disease patients 133
Diagnostic performance of a fully automated chemiluminescent enzyme immunoassay for Alzheimer's disease diagnosis 133
Brain arteriovenous malformations and seizures: an Italian study. 132
Characterization of Brain Lysosomal Activities in GBA-Related and Sporadic Parkinson’s Disease and Dementia with Lewy Bodies 131
Selective loss of glucocerebrosidase activity in sporadic Parkinson's disease and dementia with Lewy bodies 126
A magnetization transfer study of mild and advanced Parkinson's disease. 125
A new enzyme-linked immunosorbent assay for neurofilament light in cerebrospinal fluid: analytical validation and clinical evaluation 124
Cerebrospinal fluid neurofilament light chain tracks cognitive impairment in multiple sclerosis 123
The added value of Aβ42/Aβ40 in the CSF signature for routine diagnostics of Alzheimer's disease 121
Dural arteriovenous fistulas and headache features: an observational study 120
Substantia nigra hyperechogenicity in essential tremor and Parkinson's disease: a longitudinal study 120
Cerebrospinal fluid lysosomal enzymes and α-synuclein in Parkinson's disease. 119
Validity of cerebrovascular ICD-9-CM codes in healthcare administrative databases. The Umbria Data-Value Project 119
Alzheimer's disease and late-onset epilepsy of unknown origin: two faces of beta amyloid pathology 118
Performance of Aβ1-40, Aβ1-42, Total Tau, and Phosphorylated Tau as Predictors of Dementia in a Cohort of Patients with Mild Cognitive Impairment. 117
Diagnostic utility of cerebrospinal fluid α-synuclein in Parkinson's disease: A systematic review and meta-analysis 117
Multilevel Latent Class Models for evaluation of long term care facilities 116
2017 revisions of McDonald criteria shorten the time to diagnosis of multiple sclerosis in clinically isolated syndromes 115
Cerebrospinal fluid hemoglobin levels as markers of blood contamination: relevance for α-synuclein measurement 115
Cerebrospinal fluid biomarkers for the diagnosis and prognosis of Parkinson's disease: protocol for a systematic review and individual participant data meta-analysis 114
Occipital arteriovenous malformations andmigraine. 113
Cerebrospinal fluid Tau/α-synuclein ratio in Parkinson's disease and degenerative dementias. 113
Reliability and validity of the Italian versions of the Children's Fear Survey Schedule Dental Subscale and the Modified Child Dental Anxiety Scale 112
Extracranial Venous Drainage Pattern in Multiple Sclerosis and Healthy Controls: Application of the 2011 Diagnostic Criteria for Chronic Cerebrospinal Venous Insufficiency 111
Health technology disinvestment worldwide: Overview of programs and possible determinants 110
Changes in endolysosomal enzyme activities in cerebrospinal fluid of patients with Parkinson's disease. 109
Changes of olfactory tract in Parkinson’s disease: a DTI tractography study 109
Applicazione della Scala Sulla Qualita della vita nelle residenze protette dell'Umbria 108
Predictive value of admission blood glucose level on short-term mortality in acute cerebral ischemia. 107
The Italian version of cognitive function instrument (CFI): reliability and validity in a cohort of healthy elderly 107
T2*-weighted MRI values correlate with motor and cognitive dysfunction in Parkinson's disease 107
Cerebrospinal fluid biomarkers in Alzheimer's and Parkinson's diseases-From pathophysiology to clinical practice 107
A 1H magnetic resonance spectroscopy study in patients with obstructive sleep apnea. 106
Lower urinary tract symptoms and urodynamic dysfunction in clinically isolated syndromes suggestive of multiple sclerosis 106
Oral health knowledge level of nursing staff working in semi-intensive heart failure units 105
White Matter Hyperintensities Are No Major Confounder for Alzheimer's Disease Cerebrospinal Fluid Biomarkers 105
Stima della non autosufficienza negli anziani in Umbria 104
Lysosomal enzyme activities in human brain 104
The Italian version of Cognitive Function Instrument (CFI) for tracking changes in healthy elderly: results at 1-year follow-up 104
Association between migraine and headache attributed to stroke: a case-control study. 103
Prevalence and risk of progression of preclinical Alzheimer's disease stages: A systematic review and meta-analysis 103
Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer's disease core biomarkers in Lewy body disorders and Alzheimer's dementia 103
Epilepsy, amyloid-β, and D1 dopamine receptors: a possible pathogenetic link? 102
Cerebrospinal Fluid Biomarkers in Alzheimer's Disease: An Invaluable Tool for Clinical Diagnosis and Trial Enrichment 102
Fingerprinting Alzheimer's Disease by 1H Nuclear Magnetic Resonance Spectroscopy of Cerebrospinal Fluid 101
Treatment of multiple sclerosis relapses with high-dose methylprednisolone reduces the evolution of contrast-enhancing lesions into persistent black holes 100
Distorsione dell'immagine corporea nei DCA nei maschi 99
Performance Evaluation of an Automated ELISA System for Alzheimer's Disease Detection in Clinical Routine 99
Cerebrospinal Fluid Aβ42/40 Corresponds Better than Aβ42 to Amyloid PET in Alzheimer's Disease 99
Long-Term Risk of Stroke After Transient Global Amnesia in Two Prospective Cohorts 99
Novel noninvasive biomarkers of prodromal Alzheimer disease: The role of optical coherence tomography and optical coherence tomography–angiography 99
Impulse Control Disorders and Levodopa-Induced Dyskinesias in Parkinson's Disease: Pulsatile versus Continuous Dopaminergic Stimulation 98
New pathological findings in an international cohort of hereditary spastic paraplegia 4 patients. 97
Synaptic vesicle protein 2A tumoral expression predicts levetiracetam adverse events 97
Liverpool Adverse Events Profile: Italian validation and predictive value for dropout from antiepileptic treatment in people with epilepsy 96
Protocol for validating cardiovascular and cerebrovascular ICD-9-CM codes in healthcare administrative databases: The Umbria Data Value Project 95
Cerebrospinal fluid and serum D-serine concentrations are unaltered across the whole clinical spectrum of Alzheimer's disease 94
A systematic review found that deviations from intention-to-treat are common in randomized trials and systematic reviews 93
Underrecognition and undertreatment of dementia in Italian nursing homes. 91
Obsessive-compulsive disorder and migraine with medication-overuse headache. 89
Reciprocal Incremental Value of 18F-FDG-PET and Cerebrospinal Fluid Biomarkers in Mild Cognitive Impairment Patients Suspected for Alzheimer's Disease and Inconclusive First Biomarker 87
Diagnostic utility of CSF α-synuclein species in Parkinson's disease: Protocol for a systematic review and meta-analysis 86
Improved Cerebrospinal Fluid-Based Discrimination between Alzheimer's Disease Patients and Controls after Correction for Ventricular Volumes 86
Stopping onabotulinum treatment after the first two cycles might not be justified: Results of a real-life monocentric prospective study in chronic migraine 86
Early management of patients with medication-overuse headache: results from a multicentre clinical study 85
Parkinson's and Lewy body dementia CSF biomarkers 85
Evidence of practice effect in CANTAB spatial working memory test in a cohort of patients with mild cognitive impairment 84
Incidence and Antiseizure Medications of Post-stroke Epilepsy in Umbria: A Population-Based Study Using Healthcare Administrative Databases 83
Factors influencing the measurement of lysosomal enzymes activity in human cerebrospinal fluid. 81
Neuropsychiatric adverse events of antiepileptic drugs in brain tumour-related epilepsy: an Italian multicentre prospective observational study 81
Cerebrospinal fluid neurofilament light chain predicts disease activity after the first demyelinating event suggestive of multiple sclerosis 81
Misure relative all'obiettivo di salute numero uno del PSR 2003-2005: aspettativa di vita con e senza disabilità nella popolazione umbra. Anni 1999-2000 e 2004-2005 80
Drug-dependence behaviour and outcome of medication-overuse headache after treatment 80
Differential role of CSF alpha-synuclein species, tau, and Aβ42 in Parkinson's Disease. 80
High risk of early conversion to multiple sclerosis in clinically isolated syndromes with dissemination in space at baseline 80
The possible role of Optical Coherence Tomography (OCT) and OCT‐Angiography (OCTA) as new non‐invasive biomarkers of prodromal Alzheimer’s disease 80
Risk factors of levodopa-induced dyskinesia in Parkinson's disease: results from the PPMI cohort 79
Fibroblast growth factor-2 levels are elevated in the cerebrospinal fluid of multiple sclerosis patients. 78
Le condizioni di salute della popolazione anziana 78
Degradation of endocannabinoids in chronic migraine and medication overuse headache. 77
Condizioni di salute della popolazione anziana in Umbria negli anni 2004-2005 77
Subclinical vestibular dysfunction in migraineurs without vertigo: A Clinical study 77
Longitudinal changes in CSF alpha-synuclein species reflect Parkinson's disease progression 77
Cerebrospinal Fluid Biomarkers for Target Engagement and Efficacy in Clinical Trials for Alzheimer's and Parkinson's Diseases 76
Discovery, validation and optimization of cerebrospinal fluid biomarkers for use in Parkinson’s disease 76
Multilevel Latent Class Models for evaluation of long term care facilities 75
Antiepileptic drugs in migraine and epilepsy: Who is at increased risk of adverse events? 74
Stima della non autosufficienza negli anziani in Umbria 73
Hyposmia correlates with axial signs and gait disorder in Parkinson's disease: an Italian Olfactory Identification Test study 71
Le condizioni di salute della popolazione anziana in Umbria 70
Totale 11.098
Categoria #
all - tutte 50.626
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.626


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021138 0 0 0 0 0 0 0 0 0 0 0 138
2021/20221.066 10 189 10 26 39 15 17 279 42 74 197 168
2022/20232.007 123 392 27 173 131 246 6 94 712 5 58 40
2023/2024884 40 82 39 28 18 21 197 38 42 42 150 187
2024/20252.038 48 142 82 132 211 151 111 179 369 124 318 171
2025/20264.393 274 279 245 544 654 410 661 251 542 371 111 51
Totale 12.047